Myelo Therapeutics GMBH

UEI
G1LNCHNLYXF6
CAGE
DP990
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
International Organization
SAM.gov registration date
Founded
2013
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 $219,300

Contract awards

Quick answers

Is Myelo Therapeutics GMBH registered in SAM.gov?

Myelo Therapeutics GMBH's SAM.gov registration expired on January 14, 2026.

What is Myelo Therapeutics GMBH's CAGE code?

Myelo Therapeutics GMBH's CAGE code is DP990, and its Unique Entity ID (UEI) is G1LNCHNLYXF6.

How much has Myelo Therapeutics GMBH received in federal contracts?

Federal contracts obligated $219,300 to Myelo Therapeutics GMBH in fiscal years 2023 through 2027.

What is Myelo Therapeutics GMBH's most recent federal award?

Myelo Therapeutics GMBH's most recent federal contract award is Development of MYELO001 as an orally applied medical countermeasure for the treatment of hematopoietic acute… (75N93020C00005), from National Institute of Allergy and Infectious Diseases (NIH), on May 1, 2020.

On GovTribe

See Myelo Therapeutics GMBH's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe